ES2142430T3 - Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral. - Google Patents

Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral.

Info

Publication number
ES2142430T3
ES2142430T3 ES95111876T ES95111876T ES2142430T3 ES 2142430 T3 ES2142430 T3 ES 2142430T3 ES 95111876 T ES95111876 T ES 95111876T ES 95111876 T ES95111876 T ES 95111876T ES 2142430 T3 ES2142430 T3 ES 2142430T3
Authority
ES
Spain
Prior art keywords
oral administration
chondroitin sulphate
gel containing
pharmaceutical compounds
containing salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95111876T
Other languages
English (en)
Inventor
Luca Nocelli
Elisabetta Donati
Paolo Lualdi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IBSA Institut Biochimique SA
Original Assignee
IBSA Institut Biochimique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IBSA Institut Biochimique SA filed Critical IBSA Institut Biochimique SA
Application granted granted Critical
Publication of ES2142430T3 publication Critical patent/ES2142430T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSICIONES FARMACEUTICAS DE TIPO GEL, TOTALMENTE SOLUBLES EN AGUA QUE CONTIENEN UNA CANTIDAD TERAPEUTICAMENTE EFICAZ O AL MENOS UNA SAL DE SULFATO DE CONDROITINA, PARTICULARMENTE IDONEO PARA SU ADMINISTRACION ORAL EN EL TRATAMIENTO DE LA ARTROSIS, Y QUE CONTIENE ADEMAS DE 3 A 20 G., 1 A 5 G. DE UN AGENTE EDULCORANTE, Y 1 A 20 MG. DE UN AGENTE DE SABOR POR GRAMO DEL PRINCIPIO ACTIVO.
ES95111876T 1994-09-28 1995-07-28 Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral. Expired - Lifetime ES2142430T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941974A IT1270095B (it) 1994-09-28 1994-09-28 Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale

Publications (1)

Publication Number Publication Date
ES2142430T3 true ES2142430T3 (es) 2000-04-16

Family

ID=11369610

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95111876T Expired - Lifetime ES2142430T3 (es) 1994-09-28 1995-07-28 Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral.

Country Status (7)

Country Link
EP (1) EP0704216B1 (es)
AT (1) ATE187334T1 (es)
DE (1) DE69513767T2 (es)
ES (1) ES2142430T3 (es)
GR (1) GR3032874T3 (es)
IT (1) IT1270095B (es)
PT (1) PT704216E (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
FR2770777B1 (fr) * 1997-11-10 2000-02-25 Fabre Pierre Dermo Cosmetique Composition synergique associant de l'acs et/ou de l'adn a de l'hydroxyproline ainsi que leurs applications en nutritherapie et en cosmetologie
DK0951909T4 (da) * 1998-03-19 2011-01-24 Sigma Tau Ind Farmaceuti Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
US6054143A (en) * 1998-03-24 2000-04-25 Jones; Alonzo H. Xylitol delivery
AU2745700A (en) 1999-02-01 2000-08-18 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US20030069202A1 (en) * 2000-06-02 2003-04-10 Kern Kenneth Norman Compositions, kits, and methods for promoting defined health benefits
MXPA02011940A (es) * 2000-06-02 2003-04-22 Procter & Gamble Estuches y metodos para optimizar la eficacia de composiciones condroprotectoras.
EP1289532A2 (en) * 2000-06-02 2003-03-12 The Procter & Gamble Company Low carbohydrate compositions, kits thereof, and methods of use
ES2167251B1 (es) * 2000-07-13 2003-09-16 Bioiberica Nuevos disacaridos con accion antiartrosica.
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
ITMI20032614A1 (it) * 2003-12-30 2005-06-30 Altergon Sa Nuova composizione comprendente cs
ITMI20071120A1 (it) 2007-06-01 2008-12-02 Apharm Srl Composizione antiartrosica
FR2936712B1 (fr) * 2008-10-02 2011-07-01 Mds Lab Composition pour la prevention et/ou le traitement de l'arthrose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03500168A (ja) * 1988-06-27 1991-01-17 ライナー　ローラント 医薬の製造の為のグリコースアミノグリカンの使用
JP3207587B2 (ja) * 1993-03-04 2001-09-10 株式会社紀文フードケミファ 徐放性組成物

Also Published As

Publication number Publication date
ITMI941974A0 (it) 1994-09-28
PT704216E (pt) 2000-05-31
EP0704216A1 (en) 1996-04-03
EP0704216B1 (en) 1999-12-08
ATE187334T1 (de) 1999-12-15
GR3032874T3 (en) 2000-07-31
DE69513767D1 (de) 2000-01-13
DE69513767T2 (de) 2000-08-10
ITMI941974A1 (it) 1996-03-28
IT1270095B (it) 1997-04-28

Similar Documents

Publication Publication Date Title
Tradati et al. Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR)
CO4600739A1 (es) Formulaciones liquidas orales a base de alendronato
ES2201361T3 (es) Formulacion topica que contiene un tampon fosfato con estimulador de la permeabilidad cutanea.
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
US6828308B2 (en) Compositions and methods for the treatment or prevention of inflammation
ES2255287T3 (es) Composiciones para el tratamiento de la leucemia linfocitica cronica.
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
NZ508037A (en) A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer
AR059324A2 (es) Una forma solida de dosificacion oral
ATE174506T1 (de) Zusammensetzungen enthaltend nsaid-nanopartikel
ES2157944T3 (es) Nucleos de pastillas de liberacion inmediata de medicamentos insolubles que poseen un recubrimiento de liberacion sostenida.
KR970706830A (ko) 2, 2'-디티오-비스(에탄설포네이트)(디메스나)와 조합된 시스플라틴의 조성물(composition of cisplatin in combination with 2, 2＇-dithio-bis (ethanesulfonate) (dimesna)
CA2238271A1 (en) Pharmaceutical compositions comprising flurbiprofen
IT1296980B1 (it) Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
ATE295160T1 (de) Zusammensetzungen enthaltend isovalerianamide zusammen mit ibuprofen
PL346764A1 (en) New oral formulation for 5-ht4
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
DE69513767D1 (de) Pharmazeutische Zusammensetzung in Form eines Gels mit Chondroitinsulfat in Salzform zur oralen Verabreichung
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
ES2099649T3 (es) Nueva composicion farmaceutica destinada para la fabricacion de un polvo estable que contiene, a titulo de ingrediente activo, una asociacion de acido acetilsalicilico y de metoclopramida.
AR041069A1 (es) Composicion de tolterodina liquida oral
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina
JP2003503453A5 (ja) ガバペンチンおよびプレガバリンを含む相乗作用組成物
KR870009716A (ko) 클로르페니라민 제형

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 704216

Country of ref document: ES